Monitoring of the National Mass Drug Administration Campaign for Lymphatic Filariasis Elimination in Narmada District, Gujarat: An Experience

Authors

  • Arihant Jain Postgraduate Student, Department of Community Medicine, Lady Hardinge Medical College, New Delhi, India Author https://orcid.org/0009-0004-1076-2006
  • Lincy Ableen Lakra Postgraduate Student, Department of Community Medicine, Lady Hardinge Medical College, New Delhi, India Author https://orcid.org/0009-0004-8011-838X
  • S.K. Rasania Director Professor, Department of Community Medicine, Lady Hardinge Medical College, New Delhi, India Author

DOI:

https://doi.org/10.51957/Healthline_728_2025

Keywords:

Disease Eradication, Lymphatic Filariasis, Mass Drug Administration

Abstract

This study evaluates MDA campaign in Gujarat for lymphatic filariasis elimination in the Narmada district. While ashram schools achieved 95% coverage, household compliance reached only 75% due to work conflicts, and migrant workers showed 80% uptake with mop-up challenges. Key barriers included medical condition-related refusals (60%), fear of side effect of medication (30%), and documentation gaps (40%). Implementation challenges involved poor timing (missing 25% workers), exclusion of commercial sectors, and weak coordination.  Successful institutional delivery models contrasted with gaps requiring: 1) adjusted distribution timings, 2) targeted counselling for chronic patients, 3) workplace-based MDA, and 4) enhanced digital IEC in local dialects. The findings emphasise the need for improved microplanning, real-time monitoring, and private-sector integration.  These results demonstrate that tailored approaches targeted working populations, migrants, and comorbid patients can significantly improve compliance. The study provides actionable recommendations to strengthen MDA implementation, supporting India's 2027 elimination target through context-specific strategies that address ground-level challenges while leveraging successful institutional models.

References

1. World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2023. Wkly Epidemiol Rec. 2024;99(5):45-60

2. National Centre for Vector Borne Diseases Control (NCVBDC). Annual Report on Lymphatic Filariasis Elimination in India, 2024. New Delhi: MoHFW; 2024

3. Press Information Bureau. Union Health Minister launches nationwide MDA for Lymphatic Filariasis elimination. Government of India. 2025 Feb 10. Available from: https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2101250

4. Patel RK, Desai VK, Solanki HK. Coverage and compliance of mass drug administration for lymphatic filariasis in rural Gujarat: A cross-sectional study. Indian J Community Med. 2023;48(2):210-215. doi: 10.4103/ijcm.ijcm_921_22

5. Lahariya C, Mishra A. Strengthening mass drug administration for lymphatic filariasis elimination in India: A review. Trop Med Health. 2024;52:12. doi: 10.1186/s41182-024-00578-4 DOI: https://doi.org/10.1186/s41182-024-00578-4

Downloads

Published

21-10-2025

Issue

Section

Letter to Editor

Categories

How to Cite

1.
Jain A, Lakra LA, Rasania S. Monitoring of the National Mass Drug Administration Campaign for Lymphatic Filariasis Elimination in Narmada District, Gujarat: An Experience. Healthline. 2025;16(3):237-239. doi:10.51957/Healthline_728_2025